ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 114 filers reported holding ACCELERON PHARMA INC in Q4 2014. The put-call ratio across all filers is 0.52 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $13,576,000 | +0.3% | 78,882 | -26.8% | 0.01% | 0.0% |
| Q2 2021 | $13,531,000 | -2.5% | 107,823 | +5.4% | 0.01% | -10.0% |
| Q1 2021 | $13,877,000 | -3.1% | 102,329 | -8.6% | 0.01% | -9.1% |
| Q4 2020 | $14,327,000 | +8.0% | 111,979 | -5.0% | 0.01% | -8.3% |
| Q3 2020 | $13,264,000 | +19.4% | 117,867 | +1.0% | 0.01% | +9.1% |
| Q2 2020 | $11,113,000 | -17.8% | 116,650 | -22.5% | 0.01% | -31.2% |
| Q1 2020 | $13,522,000 | +28.4% | 150,464 | -24.3% | 0.02% | +60.0% |
| Q4 2019 | $10,534,000 | +111.9% | 198,673 | +57.9% | 0.01% | +100.0% |
| Q3 2019 | $4,972,000 | +2.3% | 125,831 | +6.3% | 0.01% | 0.0% |
| Q2 2019 | $4,862,000 | +10.8% | 118,347 | +25.5% | 0.01% | +25.0% |
| Q1 2019 | $4,390,000 | -18.3% | 94,276 | -23.6% | 0.00% | -33.3% |
| Q4 2018 | $5,373,000 | -37.3% | 123,366 | -17.5% | 0.01% | -25.0% |
| Q3 2018 | $8,563,000 | +14.9% | 149,617 | -2.6% | 0.01% | 0.0% |
| Q2 2018 | $7,451,000 | +51.1% | 153,558 | +21.8% | 0.01% | +60.0% |
| Q1 2018 | $4,930,000 | -45.6% | 126,097 | -40.9% | 0.01% | -44.4% |
| Q4 2017 | $9,056,000 | +659.1% | 213,387 | +567.6% | 0.01% | +800.0% |
| Q3 2017 | $1,193,000 | +47.1% | 31,964 | +0.6% | 0.00% | 0.0% |
| Q4 2016 | $811,000 | -32.0% | 31,768 | -3.5% | 0.00% | 0.0% |
| Q3 2016 | $1,192,000 | +6.2% | 32,931 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $1,122,000 | +24.7% | 33,012 | -3.2% | 0.00% | 0.0% |
| Q1 2016 | $900,000 | -49.9% | 34,117 | -7.5% | 0.00% | -50.0% |
| Q4 2015 | $1,798,000 | +95.2% | 36,874 | -0.3% | 0.00% | +100.0% |
| Q3 2015 | $921,000 | +19.9% | 36,981 | +52.3% | 0.00% | 0.0% |
| Q2 2015 | $768,000 | +107.6% | 24,283 | +149.8% | 0.00% | – |
| Q1 2015 | $370,000 | -2.4% | 9,721 | 0.0% | 0.00% | – |
| Q4 2014 | $379,000 | +48.6% | 9,721 | +15.3% | 0.00% | – |
| Q3 2014 | $255,000 | – | 8,431 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |